# Step 3 remediation review — `product-strategy`

- **Scope:** confirms the delta neither widens nor narrows the approved MVP scope, does not activate a conditional capability, and does not re-sequence the approved increments.
- **Authoritative inputs:** `feature-prioritization.md` §4/§6.3/§9; `mvp-release-scope.md` §5/§6.1/§10; `G7-mvp-feature-prioritization-release-scope.md` (DR-A1…DR-A5, Option A).
- **Evidence inspected:** §1.9 increment map row-by-row against §10's twelve increment headings; §1.12 against §6.1's nine conditionals; §11 N-8 against DR-A5 Option A.
- **Blocking findings:**
  - **RP-B3** — §1.9 assigned **F-22 / O-13 an owning increment (INC-8)**. Verified against `mvp-release-scope.md` §10: F-22 appears there **only** as a block that INC-8's group-channel attachment slice inherits (§8.3 contract 4), never as an INC-8 deliverable; §6.1 lists it as conditional on the D04 consent mechanism **and** the Head-Coach publication-authority gate, with no scheduled increment. Assigning it one silently extended the approved sequence. *Remediation applied:* O-13 assigned to no increment; §1.9 note 6 records the reasoning; §1.12's F-22 row cross-references it and now carries the full joint activation condition. *Re-verified:* `09-reverify.md`.
- **Non-blocking findings:** none outstanding.
- **Conditions:** the nine conditional capabilities remain inert; Option A ships the Free-default field and the S-02 build-time rule only — **no billing, no tier gating, no F-42** (§11 N-8, §1.12).
- **Disposition:** **`PASS WITH CONDITIONS`** — after RP-B3, the delta is scope-neutral.
- **Reviewer identity:** `product-strategist`, Department 01 (independent of the authoring pass).
- **Downstream effect:** none on the approved Step-2 artifacts, which are unchanged.
